BDBM530187 Preparation of 4-[2-(difluoromethyl)-3,3-difluoro-2-methyl-propanoyl]-3,5-dihydro-2H-pyrido[3,4-f][1,4]oxazepine-9-carbonitrile (Example 268) and 4-[2-(difluoromethyl)-3,3-difluoro-2-methyl-butanoyl]-3,5-dihydro-2H-pyrido[3,4-f][1,4]oxazepine-9-carbonitrile (Example 269)::US11203600, Example 268::US11203600, Example 269
SMILES CC(F)(F)C(C)(C(F)F)C(=O)N1CCOc2c(C1)cncc2C#N
InChI Key InChIKey=BFYVUBNMBWAMFR-UHFFFAOYSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 530187
TargetReceptor-interacting serine/threonine-protein kinase 1 [8-327](Human)
Denali Therapeutics
US Patent
Denali Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Test compounds were serially diluted in DMSO at 100 fold final concentrations in the assay (1% DMSO final). In each well of a 384-well Plate were dis...More data for this Ligand-Target Pair
TargetReceptor-interacting serine/threonine-protein kinase 1 [8-327](Human)
Denali Therapeutics
US Patent
Denali Therapeutics
US Patent
Affinity DataIC50: 550nMAssay Description:Test compounds were serially diluted in DMSO at 100 fold final concentrations in the assay (1% DMSO final). In each well of a 384-well Plate were dis...More data for this Ligand-Target Pair
